CRHSP-24 inhibitors represent a novel and distinctive class of chemical compounds designed to modulate the activity of the Corticotropin-Releasing Hormone (CRH) Signaling Pathway-24 (CRHSP-24). The CRHSP-24 pathway plays a pivotal role in the regulation of stress response and homeostasis within the central nervous system. At the molecular level, CRHSP-24 is intricately involved in the intricate signaling cascades triggered by the release of corticotropin-releasing hormone (CRH), a neuropeptide that orchestrates the body's stress response. The inhibitors belonging to the CRHSP-24 class function by selectively binding to key components of this pathway, thereby modulating its downstream effects.
CRHSP-24 inhibitors are characterized by their specific chemical arrangements, which enable them to interact with crucial proteins and receptors involved in the CRHSP-24 signaling cascade. Through this targeted interaction, these inhibitors exert a regulatory influence on the intricate molecular machinery responsible for stress response modulation. The pharmacological activity of CRHSP-24 inhibitors involves a nuanced interplay with components such as CRH receptors and associated proteins, ultimately influencing the signaling dynamics within neural circuits. As a result, these inhibitors have the potential to provide valuable insights into the physiological and molecular mechanisms underlying stress response regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil can affect calcium signaling pathways, which could influence the activity of CARHSP1 given its calcium-binding nature. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits the MAPK/ERK pathway, which can have downstream effects on stress response elements potentially regulated by CARHSP1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 targets the JNK signaling pathway, which can alter stress responses and mRNA stability mechanisms involving CARHSP1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 modulates the p38 MAPK pathway, which is implicated in stress response and could interact with the function of CARHSP1. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA sequesters calcium ions, potentially affecting CARHSP1's activity by altering calcium homeostasis. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-kB, a transcription factor involved in inflammatory responses, which could intersect with CARHSP1's role in stress responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, affecting the AKT signaling pathway which might have implications for CARHSP1's regulation of mRNA stability in stress conditions. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits proteasome activity, potentially affecting protein turnover and stress response pathways relevant to CARHSP1's function. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to HSP90, affecting its chaperone function which could have downstream effects on proteins regulated by CARHSP1. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone antagonizes glucocorticoid receptors, potentially influencing stress response pathways and mRNA stability processes involving CARHSP1. | ||||||